Showing results (1-10 of 328) with videos related to
Sort By:
Pageof 33
Drug Safety|June 1, 1995
Thalidomide: rationale for renewed use in immunological disordersU Schuler, G EhningerAnnals of Hematology|June 1, 1992
Prevention of viral infections after bone marrow transplantationU Schuler, G EhningerBone Marrow Transplantation|January 1, 1994
New approaches to the prophylaxis and treatment of bacterial and fungal infections in allogeneic marrow transplant recipientsU Schuler, G EhningerMycoses|January 1, 1995
[Prophylaxis and therapy of fungal infections in oncology]U Schuler, M Mölle, G EhningerCancer Chemotherapy and Pharmacology|January 1, 1987
Repeated high-dose cyclophosphamide administration in bone marrow transplantation: exposure to activated metabolitesU Schuler, G Ehninger, T WagnerOnkologie|August 1, 1987
[Pharmacokinetic aspects in the use of new cytostatic drugs]G Ehninger, U Schuler, H D WallerEuropean Journal of Gastroenterology & Hepatology|November 27, 1998
Abdominal lymphomas, convulsive seizure and coma: a case of successfully treated, advanced Whipple's disease with cerebral involvementJ Mohm, R Naumann, U Schuler, et al.Bone Marrow Transplantation|January 1, 1993
Thalidomide--the need for a new clinical evaluation of an old drugG Ehninger, K Eger, A Stuhler, et al.The Journal of Antimicrobial Chemotherapy|November 1, 1989
Absence of significant interaction of fluconazole with cyclosporinH U Krüger, U Schuler, R Zimmermann, et al.Annals of Hematology|July 1, 1996
Evaluation of procollagen-III peptide as a marker for veno-occlusive disease after bone marrow transplantationU Schuler, S Subat, H Schmidt, et al.Pageof 33